Cite

    E. Charvet et al.. “Second primary cutaneous melanoma in patients with advanced melanoma treated with anti‐programmed‐death‐receptor‐1 monoclonal antibodies.” British journal of dermatology, vol. 184, 2021, pp. 746–748. http://access.bl.uk/ark:/81055/vdc_100172213823.0x000058